In this study, we investigated the anti-tumor effects of baicalein in human endometrial cancer, a disease often associated with dysregulation of the PI3K/AKT/mTOR signaling pathway, particularly due to frequent loss of PTEN function. The gene discussed is AKT1; the disease is endometrial cancer.